PT91560A - Device for controlled release of active substances having asymmetric membranes based on cellulose derivatives and processes for preparing same - Google Patents

Device for controlled release of active substances having asymmetric membranes based on cellulose derivatives and processes for preparing same

Info

Publication number
PT91560A
PT91560A PT91560A PT9156089A PT91560A PT 91560 A PT91560 A PT 91560A PT 91560 A PT91560 A PT 91560A PT 9156089 A PT9156089 A PT 9156089A PT 91560 A PT91560 A PT 91560A
Authority
PT
Portugal
Prior art keywords
controlled release
processes
active substances
cellulose derivatives
asymmetric membranes
Prior art date
Application number
PT91560A
Other languages
English (en)
Other versions
PT91560B (pt
Inventor
John Robert Cardinal
Scott Max Herbig
Richard Wilker Korsmeyer
Jeelin Lo
Kelly Lincoln Smith
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT91560A publication Critical patent/PT91560A/pt
Publication of PT91560B publication Critical patent/PT91560B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Executing Machine-Instructions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
PT91560A 1988-08-30 1989-08-28 Dispositivos para a libertacao controlada de substancias activas, tendo membranas assimetricas a base de derivados de celulose, e processos para a sua preparacao PT91560B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (2)

Publication Number Publication Date
PT91560A true PT91560A (pt) 1990-03-30
PT91560B PT91560B (pt) 1995-05-04

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91560A PT91560B (pt) 1988-08-30 1989-08-28 Dispositivos para a libertacao controlada de substancias activas, tendo membranas assimetricas a base de derivados de celulose, e processos para a sua preparacao

Country Status (26)

Country Link
EP (1) EP0357369B1 (pt)
JP (1) JPH07112971B2 (pt)
KR (1) KR920008701B1 (pt)
CN (2) CN1058387C (pt)
AT (1) ATE89162T1 (pt)
AU (1) AU615104B2 (pt)
CA (1) CA1338552C (pt)
CZ (1) CZ277763B6 (pt)
DD (1) DD289466A5 (pt)
DE (1) DE68906488T2 (pt)
DK (1) DK175178B1 (pt)
EG (1) EG19189A (pt)
ES (1) ES2041006T3 (pt)
FI (1) FI102515B (pt)
HU (1) HU222245B1 (pt)
IE (1) IE62859B1 (pt)
IL (1) IL91398A (pt)
MX (1) MX173942B (pt)
MY (1) MY104183A (pt)
NO (1) NO179232C (pt)
NZ (1) NZ230470A (pt)
PL (1) PL163079B1 (pt)
PT (1) PT91560B (pt)
RU (2) RU1837873C (pt)
YU (1) YU47422B (pt)
ZA (1) ZA896586B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
DK0550641T3 (da) * 1990-09-28 1994-08-22 Pfizer Dispenseringsanordning indeholdende et hydrofobt medium
JPH0733645A (ja) * 1992-05-28 1995-02-03 Elan Corp Plc 錠剤製剤
TW235239B (pt) * 1992-11-20 1994-12-01 Pfizer
CA2150019C (en) * 1992-11-30 1999-01-05 Scott M. Herbig Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1151783C (zh) * 1997-07-01 2004-06-02 辉瑞产品公司 舍曲林的缓释剂型
NZ501251A (en) * 1997-07-01 2001-09-28 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2000069418A1 (en) * 1999-05-17 2000-11-23 The Dow Chemical Company Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005526104A (ja) 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2007002872A2 (en) * 2005-06-29 2007-01-04 Alza Corporation Semi-permeable compositions providing reduced drying time for osmotic dosage forms
KR101405545B1 (ko) 2005-11-28 2014-07-03 마리누스 파마슈티컬스 ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
US20220378707A1 (en) 2019-11-14 2022-12-01 Pfizer Inc. 1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
AU2021217209A1 (en) 2020-02-03 2022-09-29 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (pt) * 1960-11-29
ATE10582T1 (de) * 1981-01-22 1984-12-15 Capsugel A.G. Verfahren zur herstellung pharmazeutischer, darmloeslicher kapseln.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
DE10075031I2 (de) * 1984-08-17 2004-07-01 Wellcome Found Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
RU1837873C (ru) 1993-08-30
PT91560B (pt) 1995-05-04
IL91398A (en) 1994-05-30
JPH07112971B2 (ja) 1995-12-06
DK175178B1 (da) 2004-06-28
KR920008701B1 (ko) 1992-10-08
FI894046A0 (fi) 1989-08-29
AU4089189A (en) 1990-05-31
CZ277763B6 (en) 1993-04-14
CA1338552C (en) 1996-08-27
DE68906488T2 (de) 1993-09-09
DD289466A5 (de) 1991-05-02
IE62859B1 (en) 1995-03-08
IL91398A0 (en) 1990-04-29
NO179232B (no) 1996-05-28
EP0357369A2 (en) 1990-03-07
RU2093147C1 (ru) 1997-10-20
HU222245B1 (hu) 2003-05-28
NO893450D0 (no) 1989-08-29
MX173942B (es) 1994-04-11
KR900002821A (ko) 1990-03-23
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
NO179232C (no) 1996-09-04
ES2041006T3 (es) 1993-11-01
DK424489A (da) 1990-03-01
CN1125573A (zh) 1996-07-03
EP0357369A3 (en) 1991-10-02
FI102515B1 (fi) 1998-12-31
ZA896586B (en) 1991-04-24
PL163079B1 (pl) 1994-02-28
NO893450L (no) 1990-03-01
CN1042072A (zh) 1990-05-16
EP0357369B1 (en) 1993-05-12
ATE89162T1 (de) 1993-05-15
HUT74086A (en) 1996-11-28
EG19189A (en) 1994-11-30
YU165789A (en) 1992-05-28
AU615104B2 (en) 1991-09-19
DE68906488D1 (de) 1993-06-17
CN1058387C (zh) 2000-11-15
FI102515B (fi) 1998-12-31
FI894046A (fi) 1990-03-01
IE892771L (en) 1990-02-28
JPH02174713A (ja) 1990-07-06
YU47422B (sh) 1995-03-27
MY104183A (en) 1994-02-28
NZ230470A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
PT91560A (pt) Device for controlled release of active substances having asymmetric membranes based on cellulose derivatives and processes for preparing same
ITTO930942A0 (it) Membrane porose rivestite gas-permeabili.
DK156289D0 (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
DE68915715D1 (de) Membran-Blutoxygenator.
DE3789618D1 (de) Ionenerzeugende apparatur, dünnschichtbildende vorrichtung unter verwendung der ionenerzeugenden apparatur und ionenquelle.
NO894267D0 (no) Maskeringsmiddel for ubehagelig smak, tyggegummi som inneholder slikt middel, samt fremgangsmaate for fremstilling av det.
DE3762867D1 (de) Mesomorpher polymerwirkstoff, verwendungsfaehig zur nichtlinearoptik.
DE3789114D1 (de) Einen dünnen film enthaltende ultrafiltrationsmembran.
NO883837D0 (no) Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom.
DE68916816D1 (de) Luftgetrocknete Zelluloseacetat-Membranen.
SE8601966D0 (sv) Non-adsorptive semipermeable filtration membrane
DD130445A5 (de) Vorrichtung zur diffusion von stoffen durch semipermeable membranen
DE3863749D1 (de) Wasserabsorptionsregulierte trocknungsvorrichtung.
AT357664B (de) Vorrichtung zur diffusion von substanzen zwischen zwei fluida ueber semipermeable membranen
IT7828563A0 (it) Dispositivo per la diffusione e/o filtrazione di sostanze fra due fluidi attraverso membrane semipermeabili.
DE68921483D1 (de) Photomultiplier-Vorrichtung mit Mitteln zur Stabilisierung der Verstärkung.
NL185834C (nl) Afsluitinrichting voor een houder en membraan voor een dergelijke afsluitinrichting.
SE8801091D0 (sv) Sett och anordning for undvikande av beleggningar pa membran, avsedda for omvend osmos
ATE92361T1 (de) Kollagenfolie als pervaporationsmembran.
ATE101538T1 (de) Einen duennen film enthaltende ultrafiltrationsmembran.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941013

MM3A Annulment or lapse

Effective date: 20060413